INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY

H. Nabi; M. L. Hetland; A. G. Loft; O. Hendricks; D. Jensen; J. K. Pedersen; S. A. Just; K. Danebod; H. L. Munk; S. Kristensen; N. Manilo; A. Colic; A. Linauskas; P. H. Thygesen; L. B. Christensen; M Høgberget Kalisz; N. Lomborg; J. Grydehøj; J. Raun; R. Ahmed; F. Mehnert; N. Steen Krogh; B. Glintborg

doi:10.1136/annrheumdis-2022-eular.2306

INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY

H. Nabi, M. L. Hetland, A. G. Loft, O. Hendricks, D. Jensen, J. K. Pedersen, S. A. Just, K. Danebod, H. L. Munk, S. Kristensen, N. Manilo, A. Colic, A. Linauskas, P. H. Thygesen, L. B. Christensen, M Høgberget Kalisz, N. Lomborg, J. Grydehøj, J. Raun, R. AhmedF. Mehnert, N. Steen Krogh, B. Glintborg

Publikation: Bidrag til tidsskrift › Konferenceartikel i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	OP0065
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	81
Udgave nummer	Suppl. 1
Sider (fra-til)	45-46
Antal sider	2
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2022-eular.2306
Status	Udgivet - jun. 2022
Begivenhed	Annual European Congress of Rheumatology, EULAR 2022 - Copenhagen, Danmark Varighed: 1 jun. 2022 → 4 jun. 2022 https://www.congress.eular.org/

Konference

Konference	Annual European Congress of Rheumatology, EULAR 2022
Land/Område	Danmark
By	Copenhagen
Periode	01/06/2022 → 04/06/2022
Internetadresse	https://www.congress.eular.org/

Bibliografisk note

Abstrakt No. OP0065

Adgang til dokumentet

10.1136/annrheumdis-2022-eular.2306

Citationsformater

Nabi, H., Hetland, M. L., Loft, A. G., Hendricks, O., Jensen, D., Pedersen, J. K., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L. B., Kalisz, M. H., Lomborg, N., Grydehøj, J., Raun, J., ... Glintborg, B. (2022). INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY. Annals of the Rheumatic Diseases, 81(Suppl. 1), 45-46. [OP0065]. https://doi.org/10.1136/annrheumdis-2022-eular.2306

@inproceedings{4cc6fedb20ef4388be64e4ca34806f1f,

title = "INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY",

author = "H. Nabi and Hetland, {M. L.} and Loft, {A. G.} and O. Hendricks and D. Jensen and Pedersen, {J. K.} and Just, {S. A.} and K. Danebod and Munk, {H. L.} and S. Kristensen and N. Manilo and A. Colic and A. Linauskas and Thygesen, {P. H.} and Christensen, {L. B.} and Kalisz, {M H{\o}gberget} and N. Lomborg and J. Grydeh{\o}j and J. Raun and R. Ahmed and F. Mehnert and Krogh, {N. Steen} and B. Glintborg",

note = "Abstract No. OP0065; Annual European Congress of Rheumatology, EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

month = jun,

doi = "10.1136/annrheumdis-2022-eular.2306",

language = "English",

volume = "81",

pages = "45--46",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

url = "https://www.congress.eular.org/",

}

Nabi, H, Hetland, ML, Loft, AG, Hendricks, O, Jensen, D, Pedersen, JK, Just, SA, Danebod, K, Munk, HL, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, PH, Christensen, LB, Kalisz, MH, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, NS & Glintborg, B 2022, 'INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY', Annals of the Rheumatic Diseases, bind 81, nr. Suppl. 1, OP0065, s. 45-46. https://doi.org/10.1136/annrheumdis-2022-eular.2306

INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY. / Nabi, H.; Hetland, M. L.; Loft, A. G. et al.

I: Annals of the Rheumatic Diseases, Bind 81, Nr. Suppl. 1, OP0065, 06.2022, s. 45-46.

Publikation: Bidrag til tidsskrift › Konferenceartikel i tidsskrift › Forskning › peer review

TY - GEN

T1 - INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY

AU - Nabi, H.

AU - Hetland, M. L.

AU - Loft, A. G.

AU - Hendricks, O.

AU - Jensen, D.

AU - Pedersen, J. K.

AU - Just, S. A.

AU - Danebod, K.

AU - Munk, H. L.

AU - Kristensen, S.

AU - Manilo, N.

AU - Colic, A.

AU - Linauskas, A.

AU - Thygesen, P. H.

AU - Christensen, L. B.

AU - Kalisz, M Høgberget

AU - Lomborg, N.

AU - Grydehøj, J.

AU - Raun, J.

AU - Ahmed, R.

AU - Mehnert, F.

AU - Krogh, N. Steen

AU - Glintborg, B.

N1 - Abstract No. OP0065

PY - 2022/6

Y1 - 2022/6

U2 - 10.1136/annrheumdis-2022-eular.2306

DO - 10.1136/annrheumdis-2022-eular.2306

M3 - Conference article in Journal

VL - 81

SP - 45

EP - 46

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 1

M1 - OP0065

T2 - Annual European Congress of Rheumatology, EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -